Anti-cancer effect of engineered recombinant interleukin 18.
Adv Clin Exp Med. 2020 Oct;29(10):1135-1143. doi: 10.17219/acem/126298.
Adv Clin Exp Med. 2020.
PMID: 33031647
Free article.